Edition:
India

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

3.00USD
23 Feb 2018
Change (% chg)

$-0.02 (-0.66%)
Prev Close
$3.02
Open
$3.05
Day's High
$3.05
Day's Low
$2.96
Volume
66,498
Avg. Vol
152,678
52-wk High
$9.53
52-wk Low
$2.75

Select another date:

Wed, Feb 14 2018

BRIEF-Teligent Inc Announces FDA Approval Of Betamethasone Dipropionate Lotion USP 0.05 Pct

* TELIGENT INC ANNOUNCES FDA APPROVAL OF BETAMETHASONE DIPROPIONATE LOTION USP (AUGMENTED), 0.05%

BRIEF-Teligent Appoints Damian Finio As Chief Financial Officer

* TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER

BRIEF-TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%

* TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%

BRIEF-TELIGENT ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%

* TELIGENT, INC. ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%

BRIEF-Teligent announces FDA approval of betamethasone dipropionate ointment usp (augmented), 0.05%​

* Announces FDA approval of betamethasone dipropionate ointment USP (augmented), 0.05%​

BRIEF-Teligent posts Q3 qtrly ‍loss per share $0.12​

* Q3 earnings per share view $-0.01, revenue view $19.1 million -- Thomson Reuters I/B/E/S

BRIEF-Teligent announces FDA approval of partnered ANDA for Desonide Lotion

* Teligent Inc announces FDA approval of partnered ANDA for Desonide Lotion, 0.05 pct

BRIEF-Teligent Inc announces FDA approval of triamcinolone acetonide cream USP, 0.1%

* Teligent Inc announces FDA approval of triamcinolone Acetonide Cream USP, 0.1%

Select another date: